25 transgender persons consume 'phenyl' in Indore; hospitalised
Indore(PTI): Nearly 25 persons from the transgender community in Indore claimed to have consumed phenyl, following which they were hospitalised, an official said.
None of the patients was in a critical condition, Dr Basant Kumar Ningwal, Superintendent-in-Charge of the government-run Maharaja Yashwantrao Hospital, told PTI on Wednesday.
"Around 25 persons from the transgender community have been admitted to our hospital. They claimed to have consumed phenyl together on Wednesday night, but this cannot be immediately confirmed," the official said.
What triggered the mass act was not yet clear.
Asked about the incident, Additional Deputy Commissioner of Police Rajesh Dandotiya said, "Only after investigation will it become clear as to what substance the transgender community people had consumed, and why."
Another police official said the incident may be related to a dispute between two local groups of the transgender community.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Banned tobacco products seized in Ulhasnagar, one arrested
Thane (PTI): Police have arrested a 26-year-old man and seized banned tobacco products valued at more than Rs 5 lakh following a raid in the Ulhasnagar area of Thane district, an official said on Saturday.
The operation was conducted on the premises late Wednesday night near Shahad gate, based on a complaint filed by officials from the Food and Drug Administration (FDA), a police officer said, adding that a police team found a large consignment of contraband from different brands, stocked for illegal sale.
The arrested accused has been identified as Arbaz Nasir Khan (26). Two other suspects have been named as wanted in the case, and a hunt has been launched to nab them.
The seized tobacco products are valued at approximately Rs 5,05,658.
An FIR has been registered at the Ulhasnagar police station under various sections of the Bharatiya Nyaya Sanhita (BNS), along with relevant provisions of FDA regulations.
